Wanming He
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in ⓘ
-
- Pharmacovigilance and Adverse Drug Reactions 2
-
- Cancer, Lipids, and Metabolism 3
- Cancer-related molecular mechanisms research 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Min Shi (9 shared papers)Qiong Huang (8 shared papers)Shuyi Zhang (7 shared papers)Shumin Dong (5 shared papers)Zhaowei Wen (3 shared papers)Xingbin Hu (3 shared papers)Zhao Yang (3 shared papers)Yajing Liu (1 shared paper)
- Journals
- Expert Opinion on Drug Safety (2 papers)Frontiers in Oncology (2 papers)Molecular Cancer (2 papers)Neoplasia (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Wanming He
11 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 782
- Molecular Biology 1.0k
- Pulmonary and Respiratory Medicine 343
- Oncology 214
- Cell Biology 100
Countries citing papers authored by Wanming He
This map shows the geographic impact of Wanming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanming He more than expected).
Fields of papers citing papers by Wanming He
This network shows the impact of papers produced by Wanming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanming He. The network helps show where Wanming He may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanming He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway Hit paper breakdown → | 2017 | 556 |
| 2 | 2017 | 229 | |
| 3 | 2019 | 228 | |
| 4 | 2018 | 197 | |
| 5 | Fluid shear stress and tumor metastasis. | 2018 | 155 |
| 6 | 2018 | 94 | |
| 7 | 2018 | 85 | |
| 8 | 2016 | 42 | |
| 9 | 2018 | 5 | |
| 10 | 2024 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 |
About Wanming He
Wanming He is a scholar working on Toxicology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Statistics and Probability, having authored 14 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Cancer, Lipids, and Metabolism (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Cancer Research (782 citations), Molecular Biology (1.0k citations), Pulmonary and Respiratory Medicine (343 citations), Oncology (214 citations) and Cell Biology (100 citations). Wanming He has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Min Shi, Qiong Huang, Shuyi Zhang, Shumin Dong, Zhaowei Wen, Xingbin Hu, Zhao Yang, Yajing Liu, Wangjun Liao and Bishan Liang. Their work appears in journals such as Expert Opinion on Drug Safety, Frontiers in Oncology, Molecular Cancer, Neoplasia and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.